000 01489 a2200361 4500
005 20250515155214.0
264 0 _c20090608
008 200906s 0 0 eng d
022 _a0934-0874
024 7 _a10.1111/j.1432-2277.2008.00830.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSakai, Tetsuro
245 0 0 _aInitial experience using continuous intravenous treprostinil to manage pulmonary arterial hypertension in patients with end-stage liver disease.
_h[electronic resource]
260 _bTransplant international : official journal of the European Society for Organ Transplantation
_cMay 2009
300 _a554-61 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAntihypertensive Agents
_xadministration & dosage
650 0 4 _aEpoprostenol
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHemodynamics
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHypertension, Pulmonary
_xdrug therapy
650 0 4 _aInfusions, Intravenous
650 0 4 _aLiver Failure
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
700 1 _aPlaninsic, Raymond M
700 1 _aMathier, Michael A
700 1 _ade Vera, Michael E
700 1 _aVenkataramanan, Raman
773 0 _tTransplant international : official journal of the European Society for Organ Transplantation
_gvol. 22
_gno. 5
_gp. 554-61
856 4 0 _uhttps://doi.org/10.1111/j.1432-2277.2008.00830.x
_zAvailable from publisher's website
999 _c18621618
_d18621618